Fine Needle Aspiration

Fine Needle Aspiration — Lesson Overview

What Is Fine Needle Aspiration?

Fine needle aspiration (FNA) is a minimally invasive diagnostic technique in which a small-gauge needle — typically between 22 and 25 gauge — is passed into a target lesion to aspirate individual cells and small tissue fragments for cytological analysis. Rather than obtaining a core of intact tissue architecture as in core needle biopsy, FNA harvests a cellular sample that is smeared onto glass slides, stained, and examined by a cytopathologist to characterize the cellular composition of the lesion and determine whether malignant, benign, or indeterminate cells are present.

FNA occupies a unique and essential role in the diagnostic toolkit of interventional radiology and clinical medicine. It is the procedure of choice for thyroid nodules, where it remains the single most important tool in guiding management decisions, and plays a central role in the evaluation of salivary gland masses, lymph nodes, breast lesions, and superficial soft tissue tumors. Its greatest strengths are its minimal invasiveness, low complication profile, rapid turnaround when performed with on-site cytopathology evaluation, and ability to sample lesions in anatomically sensitive locations where a larger core needle would carry unacceptable risk.

However, FNA has important limitations that distinguish it from core needle biopsy. Because it yields individual cells rather than intact tissue cores, it cannot provide information about histologic architecture — the spatial organization of cells within tissue — which is often essential for definitive tumor classification, grading, and increasingly for molecular and immunohistochemical profiling that guides targeted therapy selection. Understanding when FNA is the right tool, when it must be supplemented by core biopsy, and how to maximize specimen adequacy through meticulous technique and close collaboration with cytopathology are the central skills this lesson is designed to build.

What You'll Learn in This Video

By the end of this lesson, you will be able to:

• Define fine needle aspiration and explain how it differs from core needle biopsy, including the differences in needle gauge, tissue yield, specimen type, diagnostic information obtained, and the clinical scenarios where each technique is the preferred or required approach

• Identify the indications and contraindications for FNA, including the lesion types and anatomic locations where FNA is first-line, situations where core biopsy is preferred from the outset, and patient or lesion factors that affect the feasibility and safety of the procedure

• Understand FNA needle design and selection, including the range of gauge sizes used, the differences between standard hypodermic needles and dedicated aspiration needles, the role of needle length in reaching deep versus superficial targets, and how gauge selection affects cellular yield and sample quality

• Recognize the most common FNA targets and their site-specific considerations, including thyroid nodules evaluated by the Bethesda reporting system, salivary gland masses, cervical and axillary lymph nodes for oncologic staging, breast lesions in the triple assessment framework, and superficial soft tissue masses

• Understand the two principal aspiration techniques — the capillary (non-aspiration) technique, in which the needle is moved through the lesion without suction to allow capillary filling, and the aspiration technique, in which negative pressure is applied via syringe — including the advantages and limitations of each and when one is favored over the other

• Walk through the step-by-step FNA procedure, including lesion localization with palpation or imaging guidance, skin preparation, local anesthesia consideration for superficial targets, needle insertion and fanning technique within the lesion, recognition of adequate cellular uptake, needle withdrawal, and immediate specimen preparation

• Understand specimen preparation techniques, including direct smear preparation with air-dried and alcohol-fixed slides for different staining protocols, liquid-based cytology preparation, and the use of rinse material for cell block preparation — and recognize how preparation method affects downstream diagnostic capability including immunohistochemistry and molecular testing

• Recognize the critical role of Rapid On-Site Evaluation (ROSE) in FNA procedures, including how an on-site cytopathologist or cytotechnologist assesses smear adequacy in real time, guides the number of passes required, directs triage of material for ancillary studies, and dramatically reduces non-diagnostic rates compared to procedures performed without on-site evaluation

• Understand the Bethesda System for Reporting Thyroid Cytopathology, including the six diagnostic categories from non-diagnostic through malignant, the associated risk of malignancy for each category, and how cytology results translate into clinical management recommendations including repeat FNA, molecular testing, surveillance, or surgical referral

• Understand ancillary studies that can be performed on FNA material, including immunocytochemistry, flow cytometry for lymphoma evaluation, BRAF and RAS mutation testing for thyroid nodules, microbiologic culture for infectious targets, and the importance of pre-procedure communication with pathology to ensure material is triaged appropriately

• Identify the causes and management of non-diagnostic FNA specimens, including cystic lesion fluid without epithelial cells, hemorrhagic specimens that obscure cellular detail, inadequate passes through fibrotic or necrotic lesions, and suboptimal smear preparation — and understand the decision-making process around repeat FNA, transition to core needle biopsy, or molecular testing on available material

• Recognize complications of FNA and understand their relative rarity compared to core biopsy, including local hematoma, vasovagal reaction, infection, and the theoretical but clinically rare concern of needle track seeding — and understand post-procedure care and discharge instructions appropriate to each anatomic site

• Understand the limitations of FNA in the modern era of precision oncology, including the inability to assess histologic architecture, challenges in providing sufficient material for comprehensive molecular profiling and next-generation sequencing, and the growing trend toward core needle biopsy or combined FNA plus core approaches to meet the tissue demands of contemporary cancer care